查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1742536

药物输送系统市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 187 Pages | 商品交期: 2-10个工作天内

价格

药物输送系统市场 - 报告范围

TMR 的全球药物输送系统市场报告研究了过去和目前的成长趋势和机会，旨在深入了解 2025 年至 2035 年预测期内的市场指标。该报告提供了 2019 年至 2035 年期间全球药物输送系统市场的收入，以 2025 年为基准年，2035 年为预测年。该报告还提供了 2025 年至 2035 年全球药物输送系统市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括分析师对关键意见领袖、产业领导者和舆论领袖进行访谈。次要研究则参考了主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解药物输送系统市场。

市场概况
2024 年的市场价值 2659亿美元
2035年的市场价值 4629亿美元
复合年增长率 5.1%

本报告深入探讨了全球药物输送系统市场的竞争格局。该报告确定了全球药物输送系统市场的主要参与者，并根据不同属性对每家公司进行了分析。本报告对全球药物输送系统市场参与者的属性进行了分析，包括公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球药物传输系统市场分析与预测

第五章：关键见解

  • 主要地区/国家的医疗保健支出
  • 药物输送系统的技术进步
  • 主要地区/国家的监管情况
  • 波特五力分析
  • 大环境分析
  • 重要产业事件（合作伙伴关係、协作、产品审批、併购）

第六章：全球市场分析与预测：依类型

  • 介绍和定义
  • 主要发现/进展
  • 2020-2035年各类型市场价值预测
    • 口服给药系统
      • 控释药物输送
      • 其他口服药物输送
    • 注射给药系统
      • 注射药物输送系统
      • 注射装置
    • 经皮给药系统
    • 吸入给药系统
    • 植入式药物传输系统
    • 其他的
  • 不同类型的市场吸引力

第七章：全球市场分析与预测：按应用

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年各应用市场价值预测
    • 肿瘤疾病
    • 传染病
    • 呼吸系统疾病
    • 心血管疾病
    • 自体免疫疾病
    • 中枢神经系统疾病
    • 其他的
  • 按应用分類的市场吸引力

第八章：全球市场分析与预测：按最终用户

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年终端用户市场价值预测
    • 医院
    • 门诊手术中心
    • 家庭护理设置
    • 其他的
  • 最终用户的市场吸引力

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第十二章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太其他地区
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析（2024年）
  • 公司简介
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Terumo Medical Corporation
    • Medtronic plc
    • Koninklijke Philips NV
    • Baxter International Inc.
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Teleflex Incorporated
    • Novartis AG
    • Gerresheimer AG
    • Abbott
    • Ypsomed AG
    • SHL Medical
    • Owen Mumford
Product Code: TMRGL41543

Drug Delivery Systems Market - Scope of Report

TMR's report on the global drug delivery systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug delivery systems market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug delivery systems market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug delivery systems market.

Market Snapshot
Market Value in 2024US$ 265.9 Bn
Market Value in 2035US$ 462.9 Bn
CAGR5.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug delivery systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug delivery systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug delivery systems market.

The report delves into the competitive landscape of the global drug delivery systems market. Key players operating in the global drug delivery systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug delivery systems market profiled in this report.

Key Questions Answered in global drug delivery systems Market Report:

  • What is the sales/revenue generated by drug delivery systems across all regions during the forecast period?
  • What are the opportunities in the global drug delivery systems market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug Delivery Systems Market - Research Objectives and Research Approach

The comprehensive report on the global drug delivery systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug delivery systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug delivery systems market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug Delivery Systems Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Delivery Systems Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements in Drug Delivery Systems
  • 5.3. Regulatory Scenario across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTLE Analysis
  • 5.6. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)

6. Global Drug Delivery Systems Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2035
    • 6.3.1. Oral Drug Delivery System
      • 6.3.1.1. Controlled-release Drug Delivery
      • 6.3.1.2. Other Oral Drug Delivery
    • 6.3.2. Injection-based Drug Delivery System
      • 6.3.2.1. Injectable Drug Delivery System
      • 6.3.2.2. Injectable Devices
    • 6.3.3. Transdermal Drug Delivery System
    • 6.3.4. Inhalation Drug Delivery System
    • 6.3.5. Implantable Drug Delivery System
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Type

7. Global Drug Delivery Systems Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2035
    • 7.3.1. Oncological Disorders
    • 7.3.2. Infectious Diseases
    • 7.3.3. Respiratory Disorders
    • 7.3.4. Cardiovascular Disorders
    • 7.3.5. Autoimmune Disorders
    • 7.3.6. CNS Disorders
    • 7.3.7. Others
  • 7.4. Market Attractiveness By Application

8. Global Drug Delivery Systems Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2035
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Homecare Settings
    • 8.3.4. Others
  • 8.4. Market Attractiveness By End-user

9. Global Drug Delivery Systems Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Drug Delivery Systems Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type, 2020-2035
    • 10.2.1. Oral Drug Delivery System
      • 10.2.1.1. Controlled-release Drug Delivery
      • 10.2.1.2. Other Oral Drug Delivery
    • 10.2.2. Injection-based Drug Delivery System
      • 10.2.2.1. Injectable Drug Delivery System
      • 10.2.2.2. Injectable Devices
    • 10.2.3. Transdermal Drug Delivery System
    • 10.2.4. Inhalation Drug Delivery System
    • 10.2.5. Implantable Drug Delivery System
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Application, 2020-2035
    • 10.3.1. Oncological Disorders
    • 10.3.2. Infectious Diseases
    • 10.3.3. Respiratory Disorders
    • 10.3.4. Cardiovascular Disorders
    • 10.3.5. Autoimmune Disorders
    • 10.3.6. CNS Disorders
    • 10.3.7. Others
  • 10.4. Market Value Forecast By End-user, 2020-2035
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Drug Delivery Systems Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2035
    • 11.2.1. Oral Drug Delivery System
      • 11.2.1.1. Controlled-release Drug Delivery
      • 11.2.1.2. Other Oral Drug Delivery
    • 11.2.2. Injection-based Drug Delivery System
      • 11.2.2.1. Injectable Drug Delivery System
      • 11.2.2.2. Injectable Devices
    • 11.2.3. Transdermal Drug Delivery System
    • 11.2.4. Inhalation Drug Delivery System
    • 11.2.5. Implantable Drug Delivery System
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Application, 2020-2035
    • 11.3.1. Oncological Disorders
    • 11.3.2. Infectious Diseases
    • 11.3.3. Respiratory Disorders
    • 11.3.4. Cardiovascular Disorders
    • 11.3.5. Autoimmune Disorders
    • 11.3.6. CNS Disorders
    • 11.3.7. Others
  • 11.4. Market Value Forecast By End-user, 2020-2035
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Homecare Settings
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Drug Delivery Systems Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2035
    • 12.2.1. Oral Drug Delivery System
      • 12.2.1.1. Controlled-release Drug Delivery
      • 12.2.1.2. Other Oral Drug Delivery
    • 12.2.2. Injection-based Drug Delivery System
      • 12.2.2.1. Injectable Drug Delivery System
      • 12.2.2.2. Injectable Devices
    • 12.2.3. Transdermal Drug Delivery System
    • 12.2.4. Inhalation Drug Delivery System
    • 12.2.5. Implantable Drug Delivery System
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Application, 2020-2035
    • 12.3.1. Oncological Disorders
    • 12.3.2. Infectious Diseases
    • 12.3.3. Respiratory Disorders
    • 12.3.4. Cardiovascular Disorders
    • 12.3.5. Autoimmune Disorders
    • 12.3.6. CNS Disorders
    • 12.3.7. Others
  • 12.4. Market Value Forecast By End-user, 2020-2035
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Homecare Settings
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Drug Delivery Systems Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2035
    • 13.2.1. Oral Drug Delivery System
      • 13.2.1.1. Controlled-release Drug Delivery
      • 13.2.1.2. Other Oral Drug Delivery
    • 13.2.2. Injection-based Drug Delivery System
      • 13.2.2.1. Injectable Drug Delivery System
      • 13.2.2.2. Injectable Devices
    • 13.2.3. Transdermal Drug Delivery System
    • 13.2.4. Inhalation Drug Delivery System
    • 13.2.5. Implantable Drug Delivery System
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Application, 2020-2035
    • 13.3.1. Oncological Disorders
    • 13.3.2. Infectious Diseases
    • 13.3.3. Respiratory Disorders
    • 13.3.4. Cardiovascular Disorders
    • 13.3.5. Autoimmune Disorders
    • 13.3.6. CNS Disorders
    • 13.3.7. Others
  • 13.4. Market Value Forecast By End-user, 2020-2035
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Homecare Settings
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Drug Delivery Systems Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2035
    • 14.2.1. Oral Drug Delivery System
      • 14.2.1.1. Controlled-release Drug Delivery
      • 14.2.1.2. Other Oral Drug Delivery
    • 14.2.2. Injection-based Drug Delivery System
      • 14.2.2.1. Injectable Drug Delivery System
      • 14.2.2.2. Injectable Devices
    • 14.2.3. Transdermal Drug Delivery System
    • 14.2.4. Inhalation Drug Delivery System
    • 14.2.5. Implantable Drug Delivery System
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Application, 2020-2035
    • 14.3.1. Oncological Disorders
    • 14.3.2. Infectious Diseases
    • 14.3.3. Respiratory Disorders
    • 14.3.4. Cardiovascular Disorders
    • 14.3.5. Autoimmune Disorders
    • 14.3.6. CNS Disorders
    • 14.3.7. Others
  • 14.4. Market Value Forecast By End-user, 2020-2035
    • 14.4.1. Hospitals
    • 14.4.2. Ambulatory Surgical Centers
    • 14.4.3. Homecare Settings
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Market Share Analysis (2024)
  • 15.3. Company Profiles
    • 15.3.1. Becton, Dickinson and Company
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. B. Braun Melsungen AG
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Terumo Medical Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Medtronic plc
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Koninklijke Philips N.V.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Baxter International Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Pfizer Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Teva Pharmaceutical Industries Ltd.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Teleflex Incorporated
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Novartis AG
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Gerresheimer AG
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Abbott
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Ypsomed AG
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. SHL Medical
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Owen Mumford
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 03: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 04: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 05: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 06: Global Drug Delivery Systems Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 07: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 08: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 09: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 10: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 11: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 12: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 13: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 15: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 16: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 17: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 18: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 19: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 20: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 21: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 22: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 23: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 24: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 25: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 27: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 28: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 29: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 30: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 31: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 32: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 33: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Oral Drug Delivery System, 2020-2035
  • Table 34: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Injection-based Drug Delivery System, 2020-2035
  • Table 35: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 36: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 02: Global Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 03: Global Drug Delivery Systems Market Revenue (US$ Bn), by Oral Drug Delivery System, 2020-2035
  • Figure 04: Global Drug Delivery Systems Market Revenue (US$ Bn), by Injection-based Drug Delivery System, 2020-2035
  • Figure 05: Global Drug Delivery Systems Market Revenue (US$ Bn), by Transdermal Drug Delivery System, 2020-2035
  • Figure 06: Global Drug Delivery Systems Market Revenue (US$ Bn), by Inhalation Drug Delivery System, 2020-2035
  • Figure 07: Global Drug Delivery Systems Market Revenue (US$ Bn), by Implantable Drug Delivery System, 2020-2035
  • Figure 08: Global Drug Delivery Systems Market Revenue (US$ Bn), by Ohers, 2020-2035
  • Figure 09: Global Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 10: Global Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 11: Global Drug Delivery Systems Market Revenue (US$ Bn), by Oncological Disorders, 2020-2035
  • Figure 12: Global Drug Delivery Systems Market Revenue (US$ Bn), by Infectious Diseases, 2020-2035
  • Figure 13: Global Drug Delivery Systems Market Revenue (US$ Bn), by Respiratory Disorders, 2020-2035
  • Figure 14: Global Drug Delivery Systems Market Revenue (US$ Bn), by Cardiovascular Disorders, 2020-2035
  • Figure 15: Global Drug Delivery Systems Market Revenue (US$ Bn), by Autoimmune Disorders, 2020-2035
  • Figure 16: Global Drug Delivery Systems Market Revenue (US$ Bn), by CNS Disorders, 2020-2035
  • Figure 17: Global Drug Delivery Systems Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 18: Global Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 19: Global Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 20: Global Drug Delivery Systems Market Revenue (US$ Bn), by Hospitals, 2020-2035
  • Figure 21: Global Drug Delivery Systems Market Revenue (US$ Bn), by Ambulatory Surgical Centers, 2020-2035
  • Figure 22: Global Drug Delivery Systems Market Revenue (US$ Bn), by Homecare Settings, 2020-2035
  • Figure 23: Global Drug Delivery Systems Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 24: Global Drug Delivery Systems Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 25: Global Drug Delivery Systems Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 26: North America - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 27: North America - Drug Delivery Systems Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 28: North America - Drug Delivery Systems Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 29: North America - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 30: North America - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 31: North America - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 32: North America - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 33: North America - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 34: North America - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 35: Europe - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 36: Europe - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 37: Europe - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 38: Europe - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 39: Europe - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 40: Europe - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 41: Europe - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 42: Europe - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 43: Europe - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 44: Asia Pacific - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 45: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 46: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 47: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 48: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 49: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 50: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 51: Asia Pacific - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 52: Asia Pacific - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 53: Latin America - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 54: Latin America - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 55: Latin America - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 56: Latin America - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 57: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 58: Latin America - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 59: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 60: Latin America - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 61: Latin America - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 62: Middle East & Africa - Drug Delivery Systems Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 63: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 64: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 65: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 66: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 67: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 68: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 69: Middle East & Africa - Drug Delivery Systems Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 70: Middle East & Africa - Drug Delivery Systems Market Attractiveness Analysis, By End-user, 2025-2035